Vannsh Life Sciences is an API manufacturer based in India. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Customs aggregates show $408K of exports covering 25 molecules to 7 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Visakhapatnam, India | 3021138307 |
| Molecule | Regulators | Docs |
|---|---|---|
| Capecitabine | US FDA | 1 |
| Carmustine | US FDA | 1 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $113K | 1 |
| 2025 | Not reported | $408K | 7 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Vannsh Life Sciences comes back tiered against every other supplier able to file there.
Start for free